Allspring Global Investments’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $432K | Sell |
20,407
-152,777
| -88% | -$3.24M | ﹤0.01% | 1386 |
|
|
2025
Q1 | $4.14M | Sell |
173,184
-244,148
| -59% | -$5.84M | 0.01% | 971 |
|
|
2024
Q4 | $8.71M | Buy |
417,332
+50,888
| +14% | +$1.06M | 0.01% | 805 |
|
|
2024
Q3 | $7.28M | Buy |
366,444
+217,956
| +147% | +$4.33M | 0.01% | 846 |
|
|
2024
Q2 | $2.3M | Buy |
148,488
+5,007
| +3% | +$77.6K | ﹤0.01% | 1139 |
|
|
2024
Q1 | $2.29M | Sell |
143,481
-11,753
| -8% | -$187K | ﹤0.01% | 1153 |
|
|
2023
Q4 | $2.61M | Sell |
155,234
-320,168
| -67% | -$5.38M | ﹤0.01% | 1108 |
|
|
2023
Q3 | $5.56M | Sell |
475,402
-48,676
| -9% | -$569K | 0.01% | 934 |
|
|
2023
Q2 | $7.04M | Buy |
524,078
+93,311
| +22% | +$1.25M | 0.01% | 892 |
|
|
2023
Q1 | $7.14M | Buy |
430,767
+12,873
| +3% | +$213K | 0.01% | 885 |
|
|
2022
Q4 | $7.77M | Buy |
417,894
+207,412
| +99% | +$3.86M | 0.01% | 853 |
|
|
2022
Q3 | $2.7M | Sell |
210,482
-575,082
| -73% | -$7.38M | ﹤0.01% | 1148 |
|
|
2022
Q2 | $5.51M | Sell |
785,564
-292,687
| -27% | -$2.05M | 0.01% | 963 |
|
|
2022
Q1 | $8.94M | Buy |
1,078,251
+634,522
| +143% | +$5.26M | 0.01% | 922 |
|
|
2021
Q4 | $3M | Buy |
+443,729
| New | +$3M | ﹤0.01% | 1351 |
|